Clinical Trial Update: Safety of Primaquine + Artemether-lumefantrine in G6PD Deficient Males With an Asymptomatic Malaria Infection (SAFEPRIM) [Phase 2, Phase 3]

View source ↗

Summary

Safety update from a Phase 2/3 trial evaluating primaquine plus artemether-lumefantrine in G6PD-deficient males with asymptomatic malaria. The trial assessed sa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• Coartem (artemether-lumefantrine)
• Primaquine (primaquine)

Snippet

Sponsor: London School of Hygiene and Tropical Medicine | Conditions: Malaria | Phase 2, Phase 3 | Status: COMPLETED